sees

By Dawn Chmielewski and Harshita Mary Varghese (Reuters) – Warner Bros Discovery (NASDAQ:) CEO David Zaslav anticipates a friendlier environment for deal-making under the incoming Trump administration, opening the door to industry consolidation, he said on Thursday. “That would provide real positive and accelerated impact on this industry that’s needed,”…

Philip Morris International Inc. (NYSE:) reported a robust performance in its third-quarter earnings call on October 25, 2024, with CFO Emmanuel Babeau highlighting significant organic revenue growth and a strong year-on-year increase in adjusted diluted earnings per share (EPS). The company’s success was driven by solid sales of its smoke-free…

In the third quarter of 2024, Kimberly-Clark de Mexico (KCDMX) reported a sales increase of 3.8% to MXN 13.2 billion, driven by volume growth and pricing strategies. CEO Pablo Gonzalez announced a net income rise of 9.2% to MXN 1.8 billion, with earnings per share at $0.59. The company experienced…

On Friday, H&R GmbH & Co. KGaA, also known as H&R KGaA, reported a trend of recovery in sales and earnings development by the end of the third quarter of 2024. The company’s preliminary calculations indicated an operating result (EBITDA) of €24.8 million for the third quarter, which, despite being…

‘Free Solo’ climber Alex Honnold witnessed the effects of climate change throughout his career.He’s seen glaciers and ice features melt away in Patagonia and Alaska.It inspired him to start the Honnold Foundation, investing in community-based solar energy projects. In 2023, world-famous climbers Alex Honnold (of “Free Solo” fame) and Tommy…

Investing.com — Pivotal Research Group has initiated coverage of Amazon (NASDAQ:) with a “buy” rating, citing the company’s strong organic growth potential and its robust position across several sectors. In a note dated Friday, analysts at Pivotal flagged Amazon’s broad expansion opportunities, particularly driven by its cloud services division, Amazon…

Investing.com — There is a higher potential for downside than upside in Biogen Inc’s (NASDAQ:) shares, UBS analysts said Thursday, lowering their price target on the stock from $234 to $202. The investment bank also revised its 2025 earnings per share (EPS) estimate to $17.38, down from $17.54. According to…